| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/12/2011 | CN101433672B Chinese medicament preparation for treating nosebleed and preparation method thereof |
| 01/12/2011 | CN101361810B Traditional Chinese medicine combination for treating virus lower respiratory tract infection and preparation method thereof |
| 01/12/2011 | CN101269079B Emulsion composition comprising prostaglandin E1 |
| 01/12/2011 | CN101254252B Nasosinusitis health-care composition |
| 01/12/2011 | CN101254249B Chinese and Western compound preparations for curing cough and abundant sputum symptoms and method of preparing the same |
| 01/12/2011 | CN101244120B Method for preparing sianchau particle medicinal granules with multiple health care functions |
| 01/12/2011 | CN101204386B Liquid composite containing salbutamol sulfate and ambroxol hydrochloride |
| 01/12/2011 | CN101185673B Medicine for treating nasosinusitis |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867516 Tablet with masked odor or bitterness; especially with a photostabilizer |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2469876C Benzothiazoles |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/06/2011 | WO2011000150A1 A medicinal composition for the treatment of bronchitis and preparation thereof |
| 01/06/2011 | WO2011000149A1 Pharmaceutical composition containing ephedrae for treating bronchitis and preparation method therefor |
| 01/06/2011 | WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | WO2011000053A1 Medicinal carbohydrates for treatment of respiratory conditions |
| 01/06/2011 | WO2010131009A3 Treatment of il-25 mediated diseases with tlr antagonists |
| 01/06/2011 | WO2010099319A3 Composition and methods for clotting blood |
| 01/06/2011 | US20110004164 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/06/2011 | US20110003897 Methods of engineering polar drug particles with surface-trapped hydrofluoroalkane-philes |
| 01/06/2011 | US20110003882 RNAi Modulation of AHA and Therapeutic Uses Thereof |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003863 Method for synthesizing pirfenidone |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003858 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003848 Polymorphic Form Of A [1,2,4]Triazole[4,3-A] Pyridine Derivative For Treating Inflammatory Diseases |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003835 Methods for the treatment of respiratory depression |
| 01/06/2011 | US20110003832 NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands |
| 01/06/2011 | US20110003792 Anti-inflammatory agents |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003780 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003733 Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002965 Immunomodulating compounds and related compositions and methods |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002931 Bispecific antibodies that bind to complement proteins |
| 01/06/2011 | US20110002913 Use of interleukin-4 antagonists and compositions thereof |
| 01/06/2011 | US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties |
| 01/06/2011 | US20110002854 Use of Francisella Tularensis For Prevention and Treatment of Allergic Airway Disorders |
| 01/06/2011 | CA2767130A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | CA2766239A1 Medicinal carbohydrates for treatment of respiratory conditions |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270008A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinases inhibitors |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269988A2 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269651A2 Stabilisation of macrolides |
| 01/05/2011 | EP2269648A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269647A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269602A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 01/05/2011 | EP2269600A1 Treatment of sleep disorders using eplivanserin in COPD patients |
| 01/05/2011 | EP2268793A2 Compositions methods and kits for enhancing immune response to a respiratory condition |
| 01/05/2011 | EP2268641A2 Heterocyclic compounds as adenosine receptor antagonist |
| 01/05/2011 | EP2268634A2 Processes for the preparation of bosentan and related compounds using novel intermediates |
| 01/05/2011 | EP2268611A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 01/05/2011 | EP2268281A1 Thienopyrroles and pyrrolothiazoles as new therapeutic agents |
| 01/05/2011 | EP1948176B1 Diaryl ureas for treating pulmonary hypertension |
| 01/05/2011 | EP1677795B1 Muscarinic acetycholine receptor antagonists |
| 01/05/2011 | EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP1365778B1 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | CN1985922B Medicine composition for treating common cold and its preparing method |
| 01/05/2011 | CN101939411A Compositions methods and kits for enhancing immune response to a respiratory condition |
| 01/05/2011 | CN101939327A New macrolides and their use |
| 01/05/2011 | CN101939322A Sildenafil n-oxide as prodrug |
| 01/05/2011 | CN101939320A Polymorphic form |
| 01/05/2011 | CN101939316A Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939306A Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 01/05/2011 | CN101939303A Novel crystalline forms |
| 01/05/2011 | CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 01/05/2011 | CN101939054A Organic compounds |
| 01/05/2011 | CN101939053A Soluble guanylate cyclase activators |
| 01/05/2011 | CN101939012A Macrolides for treating diseases mediated through PDE inhibition |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
| 01/05/2011 | CN101934070A Veterinary antibacterial drug composition containing lysozyme and oligosaccharide and application thereof |